New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

In many recurrent and/or metastatic cancers, the advent of immunotherapy opens up new scenarios of treatment response, with new phenomena, such as pseudoprogression and hyperprogression. Because of this, different immune-related response criteria have been developed, and new therapeutic strategies a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Andrea Alberti, Luigi Lorini, Marco Ravanelli, Francesco Perri, Marie Vinches, Paolo Rondi, Chiara Romani, Paolo Bossi
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-06-01
Col·lecció:	Vaccines
Matèries:	immunotherapy response criteria recurrent and/or metastatic head and neck squamous cell carcinoma pseudoprogression hyperprogression
Accés en línia:	https://www.mdpi.com/2076-393X/10/6/885
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!